期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Meeting Abstracts of the BACR conference:response and resistance in cancer therapy
1
作者 Tim R.Fenton michelle d.garrett +1 位作者 Martin Michaelis Mark N.Wass 《Cancer Drug Resistance》 2018年第4期266-302,共37页
1.Targeting chemoresistance induced by MYCN and ALK in neuroblastoma Louis Chesler Institute of Cancer Research,London,UK Neuroblastoma,a tumour of peripheral nerve,is the most common solid tumour of young children an... 1.Targeting chemoresistance induced by MYCN and ALK in neuroblastoma Louis Chesler Institute of Cancer Research,London,UK Neuroblastoma,a tumour of peripheral nerve,is the most common solid tumour of young children and in high-risk diseases,which comprises approximately half of patients,and the death from chemoresistant,metastatic relapse is very frequent. 展开更多
关键词 TUMOUR NEUROBLASTOMA CANCER
原文传递
What really matters-response and resistance in cancer therapy
2
作者 Tim R.Fenton michelle d.garrett +1 位作者 Mark N.Wass Martin Michaelis 《Cancer Drug Resistance》 2018年第4期200-203,共4页
From 10th to 12th September of 2018,we held the first British Association of Cancer Research(BACR)Special Conference on“Response and Resistance in Cancer Therapy”at the University of Kent,Canterbury,UK.The conferenc... From 10th to 12th September of 2018,we held the first British Association of Cancer Research(BACR)Special Conference on“Response and Resistance in Cancer Therapy”at the University of Kent,Canterbury,UK.The conference theme is the subject of this Special Issue of Cancer Drug Resistance and we hope this editorial and the following contributions,will give you an insight into this important topic. 展开更多
关键词 CANCER REALLY THERAPY
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部